Welcome!
Cancer
Global Markets
MPM Capital raises US$850 mil for cancer fund, with US$650 million from UBS
UBS clients have invested more than US$1 billion to seek out cancer treatments.
October 06, 2021
Healthcare
CDW Holding publishes research papers on new ways to target cancer stem cells
Findings include successful use of its anti-Cripto-1 antibody in suppressing cancer cell growth.
March 01, 2021
Broker's Calls
CEO’s suspension a short term roadblock in TalkMed’s long term future, says RHB
SINGAPORE (June 29): RHB is maintaining its “buy” call on TalkMed Group with a lower target price of 73 cents from $1.03 previously following Wednesday’s news of the eight-month suspension of its CEO, Dr Ang Peng Tiam, starting from July 25.
June 29, 2017
TalkMed CEO Ang Peng Tiam handed 8-month suspension for professional misconduct in 2010
SINGAPORE (June 28): Ang Peng Tiam, the executive director and CEO of healthcare company TalkMed Group, has been given an eight-month suspension by the Court of Three Judges on the grounds of professional misconduct.
June 28, 2017
Nobel prize nominee part of new Singapore eDevelopment team to research Alzheimer’s, cancer
SINGAPORE (March 13): Singapore eDevelopment (SeD) has named senior members of its new biomedical management division, SeD BioMedical, that includes two-time Nobel Prize nominee Daryl Thompson.
March 13, 2017